Stage II Adult T-Cell Leukemia/Lymphoma Terminated Phase 2 Trials for Antilymphocyte immunoglobulin (horse) (DB09312)

IndicationStatusPhase
DBCOND0036553 (Stage II Adult T-Cell Leukemia/Lymphoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01044745Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerTreatment